Women's thyroid cancer risk may be linked to reproductive lifespan and hormone therapy

Article excerpt

A study presented at the Endocrine Society's annual meeting in Chicago found that women's lifetime exposure to female hormones may increase thyroid cancer risk. Researchers examined reproductive and hormonal factors, including menstrual history, pregnancy, and hormone therapy, suggesting these variables play a role in thyroid cancer development. The findings add to growing evidence that hormonal patterns influence thyroid carcinogenesis, a disease that affects roughly three times as many women as men. The research could help identify which women face elevated risk and inform clinical screening decisions.